id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT01720836
|
77:93:chronic_disease,107:131:chronic_disease,133:148:chronic_disease,159:177:chronic_disease,182:201:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02225548
|
27:53:chronic_disease
|
Subject with a history of congenital QT prolongation
| 1
|
[
"Subject",
"with",
"a",
"history",
"of",
"congenital",
"QT",
"prolongation"
] |
[
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT00896493
|
15:18:chronic_disease
|
Those who are HIV-positive
| 1
|
[
"Those",
"who",
"are",
"HIV-positive"
] |
[
0,
0,
0,
2
] |
NCT02611063
|
20:34:treatment,80:92:chronic_disease,142:149:treatment,153:163:chronic_disease
|
Participation in a clinical trial evaluating another preventative strategy for chronic GVHD or ongoing participation in a clinical trial for therapy of acute GVHD
| 1
|
[
"Participation",
"in",
"a",
"clinical",
"trial",
"evaluating",
"another",
"preventative",
"strategy",
"for",
"chronic",
"GVHD",
"or",
"ongoing",
"participation",
"in",
"a",
"clinical",
"trial",
"for",
"therapy",
"of",
"acute",
"GVHD"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
2,
2
] |
NCT02323126
|
43:63:allergy_name
|
History of allergy or hypersensitivity to nivolumab components
| 1
|
[
"History",
"of",
"allergy",
"or",
"hypersensitivity",
"to",
"nivolumab",
"components"
] |
[
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT02310633
|
42:45:chronic_disease
|
who meet criteria for moderate or severe TBI during deployment
| 1
|
[
"who",
"meet",
"criteria",
"for",
"moderate",
"or",
"severe",
"TBI",
"during",
"deployment"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT02772302
|
1:16:chronic_disease
|
Locked-in state
| 1
|
[
"Locked-in",
"state"
] |
[
2,
2
] |
NCT02507232
|
1:6:cancer
|
Tumor is supratentorially located and measureable
| 1
|
[
"Tumor",
"is",
"supratentorially",
"located",
"and",
"measureable"
] |
[
3,
0,
0,
0,
0,
0
] |
NCT01817751
|
7:41:chronic_disease
|
Known human immunodeficiency virus (HIV) positivity
| 1
|
[
"Known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positivity"
] |
[
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02823665
|
12:20:chronic_disease
|
History of glaucoma
| 1
|
[
"History",
"of",
"glaucoma"
] |
[
0,
0,
2
] |
NCT02176161
|
28:51:treatment,53:71:treatment,73:82:treatment,84:116:treatment
|
Current or previous use of 5α-reductase inhibitors, antiandrogen drugs, metformin, oral or injectable diabetes drug
| 1
|
[
"Current",
"or",
"previous",
"use",
"of",
"5α-reductase",
"inhibitors",
",",
"antiandrogen",
"drugs",
",",
"metformin",
",",
"oral",
"or",
"injectable",
"diabetes",
"drug"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
0,
1,
1,
1,
1,
1
] |
NCT02359097
|
27:38:treatment,
|
Subject who have received ferumoxytol within 3 weeks of study entry
| 1
|
[
"Subject",
"who",
"have",
"received",
"ferumoxytol",
"within",
"3",
"weeks",
"of",
"study",
"entry"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02628535
|
1:15:chronic_disease,
|
GI perforation within 1 year
| 1
|
[
"GI",
"perforation",
"within",
"1",
"year"
] |
[
2,
2,
0,
0,
0
] |
NCT01364467
|
10:29:chronic_disease
|
signs of bacterial infection
| 1
|
[
"signs",
"of",
"bacterial",
"infection"
] |
[
0,
0,
2,
2
] |
NCT02510417
|
36:46:cancer
|
Active and uncontrolled relapse of malignancy
| 1
|
[
"Active",
"and",
"uncontrolled",
"relapse",
"of",
"malignancy"
] |
[
0,
0,
0,
0,
0,
3
] |
NCT03059030
|
100:116:chronic_disease,118:137:chronic_disease,156:180:chronic_disease,184:203:chronic_disease
|
Any serious medical condition likely to impede successful completion of the study, such as certain mental disorders, cardiac arrhythmias, and uncontrolled congestive heart failure or respiratory disease
| 1
|
[
"Any",
"serious",
"medical",
"condition",
"likely",
"to",
"impede",
"successful",
"completion",
"of",
"the",
"study",
",",
"such",
"as",
"certain",
"mental",
"disorders",
",",
"cardiac",
"arrhythmias",
",",
"and",
"uncontrolled",
"congestive",
"heart",
"failure",
"or",
"respiratory",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2
] |
NCT02474667
|
8:25:cancer,40:45:cancer,47:57:cancer,61:83:cancer,106:111:cancer,115:158:cancer
|
Has an active malignancy or history of solid, metastatic or hematologic malignancy with the exception of basal or squamous cell carcinoma in situ of the skin that has been adequately treated
| 1
|
[
"Has",
"an",
"active",
"malignancy",
"or",
"history",
"of",
"solid",
",",
"metastatic",
"or",
"hematologic",
"malignancy",
"with",
"the",
"exception",
"of",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"in",
"situ",
"of",
"the",
"skin",
"that",
"has",
"been",
"adequately",
"treated"
] |
[
0,
0,
3,
3,
0,
0,
0,
3,
0,
3,
0,
3,
3,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT02667418
|
1:12:chronic_disease
|
hypotension
| 1
|
[
"hypotension"
] |
[
2
] |
NCT01087294
|
12:24:chronic_disease,51:61:treatment,63:69:chronic_disease,81:94:chronic_disease,120:126:chronic_disease
|
History of hypertension that is not controlled by medication, stroke, or severe heart disease (donors with symptomatic angina will be excluded)
| 1
|
[
"History",
"of",
"hypertension",
"that",
"is",
"not",
"controlled",
"by",
"medication",
",",
"stroke",
",",
"or",
"severe",
"heart",
"disease",
"(",
"donors",
"with",
"symptomatic",
"angina",
"will",
"be",
"excluded",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
1,
0,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02574728
|
1:22:cancer
|
optic pathway gliomas
| 1
|
[
"optic",
"pathway",
"gliomas"
] |
[
3,
3,
3
] |
NCT02362308
|
20:38:chronic_disease,47:66:chronic_disease,68:74:chronic_disease,76:83:chronic_disease,88:113:chronic_disease
|
History of serious neurologic disease such as cerebral hemorrhage, stroke, seizure, or transient ischemic attack
| 1
|
[
"History",
"of",
"serious",
"neurologic",
"disease",
"such",
"as",
"cerebral",
"hemorrhage",
",",
"stroke",
",",
"seizure",
",",
"or",
"transient",
"ischemic",
"attack"
] |
[
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
2,
0,
2,
0,
0,
2,
2,
2
] |
NCT03137121
|
19:31:treatment,35:44:treatment,,94:110:treatment,114:130:treatment,176:208:treatment
|
Have not received chemotherapy or radiation for >14 days (advanced cancer patients receiving hormonal therapy or targeted therapy that does not come with a recommendation for prophylactic anti-emetic therapy are eligible)
| 1
|
[
"Have",
"not",
"received",
"chemotherapy",
"or",
"radiation",
"for",
">",
"14",
"days",
"(",
"advanced",
"cancer",
"patients",
"receiving",
"hormonal",
"therapy",
"or",
"targeted",
"therapy",
"that",
"does",
"not",
"come",
"with",
"a",
"recommendation",
"for",
"prophylactic",
"anti-emetic",
"therapy",
"are",
"eligible",
")"
] |
[
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT00902720
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02639065
|
32:42:allergy_name
|
History of hypersensitivity to durvalumab or any excipient
| 1
|
[
"History",
"of",
"hypersensitivity",
"to",
"durvalumab",
"or",
"any",
"excipient"
] |
[
0,
0,
0,
0,
4,
0,
0,
0
] |
NCT02785042
|
21:29:chronic_disease
|
Negative history of glaucoma (not including family history)
| 1
|
[
"Negative",
"history",
"of",
"glaucoma",
"(",
"not",
"including",
"family",
"history",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT03145298
|
8:30:chronic_disease
|
Active uncontrolled infection
| 1
|
[
"Active",
"uncontrolled",
"infection"
] |
[
0,
2,
2
] |
NCT02074631
|
,,,,189:200:treatment
|
Pregnancy or breastfeeding - menstruating females must have a negative pregnancy test prior to study enrollment and agree to repeat pregnancy testing and contraception use per protocol as pamidronate is Pregnancy Category D - positive evidence of human fetal risk based on adverse reaction data
| 1
|
[
"Pregnancy",
"or",
"breastfeeding",
"-",
"menstruating",
"females",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"prior",
"to",
"study",
"enrollment",
"and",
"agree",
"to",
"repeat",
"pregnancy",
"testing",
"and",
"contraception",
"use",
"per",
"protocol",
"as",
"pamidronate",
"is",
"Pregnancy",
"Category",
"D",
"-",
"positive",
"evidence",
"of",
"human",
"fetal",
"risk",
"based",
"on",
"adverse",
"reaction",
"data"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00969111
|
1:16:cancer,40:44:treatment,46:58:treatment,62:96:treatment
|
Prostate cancer treated primarily with open, laparoscopic or robotically assisted prostatectomy
| 1
|
[
"Prostate",
"cancer",
"treated",
"primarily",
"with",
"open",
",",
"laparoscopic",
"or",
"robotically",
"assisted",
"prostatectomy"
] |
[
3,
3,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1
] |
NCT02876302
|
43:53:cancer
|
Individuals with a history of a different malignancy are ineligible
| 1
|
[
"Individuals",
"with",
"a",
"history",
"of",
"a",
"different",
"malignancy",
"are",
"ineligible"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
0,
0
] |
NCT02541565
|
1:35:treatment
|
positron emission tomography (PET)
| 1
|
[
"positron",
"emission",
"tomography",
"(",
"PET",
")"
] |
[
1,
1,
1,
1,
0,
0
] |
NCT01953900
|
53:65:treatment
|
Recovered from the acute toxic effects of all prior chemotherapy
| 1
|
[
"Recovered",
"from",
"the",
"acute",
"toxic",
"effects",
"of",
"all",
"prior",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02465060
|
,,,,121:130:treatment
|
Absolute neutrophil count >= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)
| 1
|
[
"Absolute",
"neutrophil",
"count",
">",
"=",
"1,500/mcL",
"(",
"within",
"2",
"weeks",
"prior",
"to",
"screening",
"step",
"registration",
"and",
"within",
"4",
"weeks",
"prior",
"to",
"treatment",
"step",
"registration",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02734602
|
45:63:chronic_disease
|
First degree relative with a diagnosis of a psychotic disorder
| 1
|
[
"First",
"degree",
"relative",
"with",
"a",
"diagnosis",
"of",
"a",
"psychotic",
"disorder"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03135171
|
10:27:treatment,
|
The last radiation therapy must have occurred ≥3 weeks prior to study registration
| 1
|
[
"The",
"last",
"radiation",
"therapy",
"must",
"have",
"occurred",
"≥3",
"weeks",
"prior",
"to",
"study",
"registration"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01945814
|
1:39:treatment,44:47:chronic_disease,49:52:chronic_disease,57:67:chronic_disease
|
Treatment of reactivation or infection for EBV, CMV, or Adenovirus
| 1
|
[
"Treatment",
"of",
"reactivation",
"or",
"infection",
"for",
"EBV",
",",
"CMV",
",",
"or",
"Adenovirus"
] |
[
1,
1,
1,
1,
1,
0,
2,
0,
2,
0,
0,
2
] |
NCT01774019
|
30:42:cancer,54:71:cancer,73:102:cancer,113:134:cancer
|
Biliary strictures caused by malignancies other than pancreatic cancer, distal CBD cholangiocarcinoma and other periampullary cancers
| 1
|
[
"Biliary",
"strictures",
"caused",
"by",
"malignancies",
"other",
"than",
"pancreatic",
"cancer",
",",
"distal",
"CBD",
"cholangiocarcinoma",
"and",
"other",
"periampullary",
"cancers"
] |
[
0,
0,
0,
0,
3,
0,
0,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3
] |
NCT02281409
|
17:38:treatment
|
Subjects on any immunomodulatory drug
| 1
|
[
"Subjects",
"on",
"any",
"immunomodulatory",
"drug"
] |
[
0,
0,
0,
1,
1
] |
NCT02886572
|
53:73:cancer,75:91:cancer,93:101:cancer,103:111:cancer,117:133:cancer
|
Primary lesion with radiosensitive histology (i.e., small cell carcinoma, germ-cell tumors, lymphoma, leukemia, and multiple myeloma)
| 1
|
[
"Primary",
"lesion",
"with",
"radiosensitive",
"histology",
"(",
"i.e.",
",",
"small",
"cell",
"carcinoma",
",",
"germ-cell",
"tumors",
",",
"lymphoma",
",",
"leukemia",
",",
"and",
"multiple",
"myeloma",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
0,
3,
0,
3,
0,
0,
3,
3,
0
] |
NCT03036280
|
24:47:chronic_disease
|
Positive biomarker for brain amyloid pathology as indicated by either amyloid PET or CSF AD assessment or both
| 1
|
[
"Positive",
"biomarker",
"for",
"brain",
"amyloid",
"pathology",
"as",
"indicated",
"by",
"either",
"amyloid",
"PET",
"or",
"CSF",
"AD",
"assessment",
"or",
"both"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02744430
|
4:29:treatment
|
On immunosuppressant therapy
| 1
|
[
"On",
"immunosuppressant",
"therapy"
] |
[
0,
1,
1
] |
NCT02519322
|
,33:41:cancer,74:80:treatment,,117:128:treatment
|
Patients will have at least one melanoma deposit that can undergo serial biopsy (at least 2 time points) during the neoadjuvant phase of the protocol
| 1
|
[
"Patients",
"will",
"have",
"at",
"least",
"one",
"melanoma",
"deposit",
"that",
"can",
"undergo",
"serial",
"biopsy",
"(",
"at",
"least",
"2",
"time",
"points",
")",
"during",
"the",
"neoadjuvant",
"phase",
"of",
"the",
"protocol"
] |
[
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02520713
|
1:9:cancer
|
lymphoma
| 1
|
[
"lymphoma"
] |
[
3
] |
NCT03058679
|
1:15:chronic_disease
|
Celiac disease
| 1
|
[
"Celiac",
"disease"
] |
[
2,
2
] |
NCT00902720
|
1:10:treatment,19:28:treatment,69:79:cancer
|
radiation for the treatment or prevention of a medical condition or malignancy expected to result in permanent and complete loss of subsequent ovarian function or have a medical condition or malignancy that requires removal of all or part of one or both ovaries
| 1
|
[
"radiation",
"for",
"the",
"treatment",
"or",
"prevention",
"of",
"a",
"medical",
"condition",
"or",
"malignancy",
"expected",
"to",
"result",
"in",
"permanent",
"and",
"complete",
"loss",
"of",
"subsequent",
"ovarian",
"function",
"or",
"have",
"a",
"medical",
"condition",
"or",
"malignancy",
"that",
"requires",
"removal",
"of",
"all",
"or",
"part",
"of",
"one",
"or",
"both",
"ovaries"
] |
[
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02434809
|
32:49:treatment
|
Patient is planning to undergo radiation therapy for primary
| 1
|
[
"Patient",
"is",
"planning",
"to",
"undergo",
"radiation",
"therapy",
"for",
"primary"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02768727
|
23:46:chronic_disease
|
Current or history of chronic sleep disorders
| 1
|
[
"Current",
"or",
"history",
"of",
"chronic",
"sleep",
"disorders"
] |
[
0,
0,
0,
0,
2,
2,
2
] |
NCT02408861
|
19:50:treatment,67:78:allergy_name,87:96:treatment,
|
a brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen)
| 1
|
[
"a",
"brief",
"course",
"of",
"corticosteroids",
"for",
"prophylaxis",
"(",
"e.g.",
",",
"contrast",
"dye",
"allergy",
")",
"or",
"for",
"treatment",
"of",
"non-autoimmune",
"conditions",
"(",
"e.g.",
",",
"delayed-type",
"hypersensitivity",
"reaction",
"caused",
"by",
"contact",
"allergen",
")"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
4,
4,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02914483
|
1:36:chronic_disease
|
acute exacerbation of heart failure
| 1
|
[
"acute",
"exacerbation",
"of",
"heart",
"failure"
] |
[
2,
2,
2,
2,
2
] |
NCT02740543
|
1:11:treatment,,,,,
|
Spirometry in the past 6 months or on day of evaluation with a bronchodilator* response of ≥ 12% and 200 ml improvement in FEV
| 1
|
[
"Spirometry",
"in",
"the",
"past",
"6",
"months",
"or",
"on",
"day",
"of",
"evaluation",
"with",
"a",
"bronchodilator",
"*",
"response",
"of",
"≥",
"12",
"%",
"and",
"200",
"ml",
"improvement",
"in",
"FEV"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02575404
|
41:60:treatment
|
Patients who have previously received a galectin antagonist
| 1
|
[
"Patients",
"who",
"have",
"previously",
"received",
"a",
"galectin",
"antagonist"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01954316
|
27:51:chronic_disease,,,
|
Have clinical symptomatic congestive heart failure defined at >= Class II of the New York Heart Association functional classification system or LVEF < 50% at baseline
| 1
|
[
"Have",
"clinical",
"symptomatic",
"congestive",
"heart",
"failure",
"defined",
"at",
">",
"=",
"Class",
"II",
"of",
"the",
"New",
"York",
"Heart",
"Association",
"functional",
"classification",
"system",
"or",
"LVEF",
"<",
"50",
"%",
"at",
"baseline"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02167009
|
1:5:treatment,
|
TURP within the last two years
| 1
|
[
"TURP",
"within",
"the",
"last",
"two",
"years"
] |
[
1,
0,
0,
0,
0,
0
] |
NCT02213289
|
,31:47:treatment,59:71:treatment,79:91:treatment
|
>6 months after completion of adjuvant therapy (including chemotherapy and/or radiotherapy)
| 1
|
[
">",
"6",
"months",
"after",
"completion",
"of",
"adjuvant",
"therapy",
"(",
"including",
"chemotherapy",
"and/or",
"radiotherapy",
")"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0
] |
NCT03060772
|
12:20:chronic_disease
|
History of diabetes
| 1
|
[
"History",
"of",
"diabetes"
] |
[
0,
0,
2
] |
NCT02660528
|
1:4:chronic_disease
|
HIV
| 1
|
[
"HIV"
] |
[
2
] |
NCT00977977
|
1:30:treatment,34:58:treatment,,121:130:treatment,135:147:treatment
|
Immunosuppressive medications or experimental medications of any type during the three month period prior to initiating Rituximab and cyclosporine
| 1
|
[
"Immunosuppressive",
"medications",
"or",
"experimental",
"medications",
"of",
"any",
"type",
"during",
"the",
"three",
"month",
"period",
"prior",
"to",
"initiating",
"Rituximab",
"and",
"cyclosporine"
] |
[
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT03013543
|
6:21:chronic_disease
|
Rare genetic disease patients genetically confirmed diagnoses (may be confirmed by test at Screening)
| 1
|
[
"Rare",
"genetic",
"disease",
"patients",
"genetically",
"confirmed",
"diagnoses",
"(",
"may",
"be",
"confirmed",
"by",
"test",
"at",
"Screening",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01690468
|
31:43:treatment
|
At least one prior regimen of chemotherapy, with no maximum number of chemotherapy cycles
| 1
|
[
"At",
"least",
"one",
"prior",
"regimen",
"of",
"chemotherapy",
",",
"with",
"no",
"maximum",
"number",
"of",
"chemotherapy",
"cycles"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02786251
|
142:156:treatment
|
Use of medications that are judged by the investigators to affect the study outcome measures or increase the risk of study procedures (e.g., anticoagulants) and that cannot be temporarily discontinued for this study
| 1
|
[
"Use",
"of",
"medications",
"that",
"are",
"judged",
"by",
"the",
"investigators",
"to",
"affect",
"the",
"study",
"outcome",
"measures",
"or",
"increase",
"the",
"risk",
"of",
"study",
"procedures",
"(",
"e.g.",
",",
"anticoagulants",
")",
"and",
"that",
"can",
"not",
"be",
"temporarily",
"discontinued",
"for",
"this",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02237183
|
12:28:chronic_disease,42:66:chronic_disease,68:92:chronic_disease,94:112:chronic_disease,117:154:chronic_disease
|
ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that in the opinion of investigators would jeopardize patient safety of data integrity
| 1
|
[
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"in",
"the",
"opinion",
"of",
"investigators",
"would",
"jeopardize",
"patient",
"safety",
"of",
"data",
"integrity"
] |
[
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02064036
|
,41:52:treatment
|
within 90 days after discontinuation of dutasteride
| 1
|
[
"within",
"90",
"days",
"after",
"discontinuation",
"of",
"dutasteride"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02347891
|
30:33:chronic_disease
|
Have a historically positive HIV test or test positive at screening for HIV
| 1
|
[
"Have",
"a",
"historically",
"positive",
"HIV",
"test",
"or",
"test",
"positive",
"at",
"screening",
"for",
"HIV"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02637349
|
1:15:chronic_disease
|
Severe illness that would preclude conversation or interface with a computer (e.g.,persistent nausea/vomiting, severe pain)
| 1
|
[
"Severe",
"illness",
"that",
"would",
"preclude",
"conversation",
"or",
"interface",
"with",
"a",
"computer",
"(",
"e.g.",
",",
"persistent",
"nausea/vomiting",
",",
"severe",
"pain",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02111850
|
,,120:129:treatment
|
Women of child-bearing potential who are pregnant or breastfeeding because of the potentially dangerous effects of the treatment on the fetus or infant
| 1
|
[
"Women",
"of",
"child-bearing",
"potential",
"who",
"are",
"pregnant",
"or",
"breastfeeding",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus",
"or",
"infant"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02593123
|
1:22:cancer
|
Hodgkin lymphoma (HL)
| 1
|
[
"Hodgkin",
"lymphoma",
"(",
"HL",
")"
] |
[
3,
3,
3,
0,
0
] |
NCT02640638
|
1:15:chronic_disease,,
|
Morbid Obesity with BMI >49.99
| 1
|
[
"Morbid",
"Obesity",
"with",
"BMI",
">",
"49.99"
] |
[
2,
2,
0,
0,
0,
0
] |
NCT02359825
|
,47:61:treatment
|
repair within 48 hours of injury that require nerve grafting
| 1
|
[
"repair",
"within",
"48",
"hours",
"of",
"injury",
"that",
"require",
"nerve",
"grafting"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02657993
|
1:13:chronic_disease
|
Fibromyalgia
| 1
|
[
"Fibromyalgia"
] |
[
2
] |
NCT01620216
|
11:43:treatment
|
No active graft versus host disease (GVHD)
| 1
|
[
"No",
"active",
"graft",
"versus",
"host",
"disease",
"(",
"GVHD",
")"
] |
[
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02437851
|
,,,,,,,,,,395:404:treatment
|
all women of childbearing potential must agree to use a reliable birth control method (oral contraceptive pills, intrauterine device, Nexplanon, DepoProvera, or permanent sterilization, etc., or another acceptable method as determined by the investigator) during the entire period of the trial (3 years), and must not intend to become pregnant during study participation and for 3 months after treatment is discontinued
| 1
|
[
"all",
"women",
"of",
"childbearing",
"potential",
"must",
"agree",
"to",
"use",
"a",
"reliable",
"birth",
"control",
"method",
"(",
"oral",
"contraceptive",
"pills",
",",
"intrauterine",
"device",
",",
"Nexplanon",
",",
"DepoProvera",
",",
"or",
"permanent",
"sterilization",
",",
"etc.",
",",
"or",
"another",
"acceptable",
"method",
"as",
"determined",
"by",
"the",
"investigator",
")",
"during",
"the",
"entire",
"period",
"of",
"the",
"trial",
"(",
"3",
"years",
")",
",",
"and",
"must",
"not",
"intend",
"to",
"become",
"pregnant",
"during",
"study",
"participation",
"and",
"for",
"3",
"months",
"after",
"treatment",
"is",
"discontinued"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0
] |
NCT02050347
|
85:95:treatment
|
An immune globulin rearrangement known to be a disease marker for this patient post transplant
| 1
|
[
"An",
"immune",
"globulin",
"rearrangement",
"known",
"to",
"be",
"a",
"disease",
"marker",
"for",
"this",
"patient",
"post",
"transplant"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02663934
|
1:21:chronic_disease
|
behavioral disorders that would prevent ability to follow the protocol
| 1
|
[
"behavioral",
"disorders",
"that",
"would",
"prevent",
"ability",
"to",
"follow",
"the",
"protocol"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02105766
|
14:18:treatment
|
Eligible for HSCT
| 1
|
[
"Eligible",
"for",
"HSCT"
] |
[
0,
0,
1
] |
NCT02926378
|
1:18:chronic_disease
|
Cerebral aneurysm clips - if magnetic, can move
| 1
|
[
"Cerebral",
"aneurysm",
"clips",
"-",
"if",
"magnetic",
",",
"can",
"move"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01946074
|
17:36:treatment,111:121:treatment,125:132:treatment
|
Subjects in the combination therapy cohorts must meet the above inclusion criteria and be eligible to receive paclitaxel or FOLFIRI per most current prescribing information, or at the discretion of the Investigator
| 1
|
[
"Subjects",
"in",
"the",
"combination",
"therapy",
"cohorts",
"must",
"meet",
"the",
"above",
"inclusion",
"criteria",
"and",
"be",
"eligible",
"to",
"receive",
"paclitaxel",
"or",
"FOLFIRI",
"per",
"most",
"current",
"prescribing",
"information",
",",
"or",
"at",
"the",
"discretion",
"of",
"the",
"Investigator"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02633163
|
,43:56:treatment,,81:97:treatment,127:139:treatment
|
Therapy must include at least 6 months of mycophenolate or at least 3 months of cyclophosphamide followed by mycophenolate or azathioprine
| 1
|
[
"Therapy",
"must",
"include",
"at",
"least",
"6",
"months",
"of",
"mycophenolate",
"or",
"at",
"least",
"3",
"months",
"of",
"cyclophosphamide",
"followed",
"by",
"mycophenolate",
"or",
"azathioprine"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1
] |
NCT02204098
|
51:64:cancer
|
Newly diagnosed histologically confirmed invasive breast cancer
| 1
|
[
"Newly",
"diagnosed",
"histologically",
"confirmed",
"invasive",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
3,
3
] |
NCT02458014
|
26:36:cancer
|
No active or co-existing malignancy
| 1
|
[
"No",
"active",
"or",
"co-existing",
"malignancy"
] |
[
0,
0,
0,
0,
3
] |
NCT01676259
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02554903
|
1:54:treatment,56:93:treatment,101:113:treatment,125:141:treatment,146:175:treatment,183:195:treatment,221:230:treatment
|
Treatment with endothelin receptor antagonists (ERAs), phosphodiesterase-5 (PDE5) inhibitors, i.v., subcutaneous (s.c.), or oral prostanoids, or guanylate cyclase stimulators within 7 days prior to Baseline RHC or study treatment initiation
| 1
|
[
"Treatment",
"with",
"endothelin",
"receptor",
"antagonists",
"(",
"ERAs",
")",
",",
"phosphodiesterase-5",
"(",
"PDE5",
")",
"inhibitors",
",",
"i.v.",
",",
"subcutaneous",
"(",
"s.c.",
")",
",",
"or",
"oral",
"prostanoids",
",",
"or",
"guanylate",
"cyclase",
"stimulators",
"within",
"7",
"days",
"prior",
"to",
"Baseline",
"RHC",
"or",
"study",
"treatment",
"initiation"
] |
[
1,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0
] |
NCT02145351
|
35:48:chronic_disease
|
Significant left sided structural valve disease (>mild stenosis, >moderate regurgitation)
| 1
|
[
"Significant",
"left",
"sided",
"structural",
"valve",
"disease",
"(",
">",
"mild",
"stenosis",
",",
">",
"moderate",
"regurgitation",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02908841
|
,40:52:treatment
|
Women scheduled for standard multiport laparoscopic
| 1
|
[
"Women",
"scheduled",
"for",
"standard",
"multiport",
"laparoscopic"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02227199
|
54:66:treatment
|
Patients must be anticipated to complete 2 cycles of chemotherapy
| 1
|
[
"Patients",
"must",
"be",
"anticipated",
"to",
"complete",
"2",
"cycles",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01754298
|
1:23:chronic_disease
|
inflammatory arthritis
| 1
|
[
"inflammatory",
"arthritis"
] |
[
2,
2
] |
NCT02573883
|
1:34:treatment
|
Previous pelvic radiation therapy
| 1
|
[
"Previous",
"pelvic",
"radiation",
"therapy"
] |
[
1,
1,
1,
1
] |
NCT02572323
|
12:49:chronic_disease,111:117:chronic_disease,132:150:chronic_disease,152:181:chronic_disease,193:220:chronic_disease
|
History of neurocognitive confounding conditions that explain current impairment including but not limited to stroke, head injury, psychotic disorder, active substance use disorder by DSM, or opportunistic CNS infection
| 1
|
[
"History",
"of",
"neurocognitive",
"confounding",
"conditions",
"that",
"explain",
"current",
"impairment",
"including",
"but",
"not",
"limited",
"to",
"stroke",
",",
"head",
"injury",
",",
"psychotic",
"disorder",
",",
"active",
"substance",
"use",
"disorder",
"by",
"DSM",
",",
"or",
"opportunistic",
"CNS",
"infection"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2
] |
NCT02549833
|
34:51:chronic_disease
|
History or clinical suspicion of neurofibromatosis
| 1
|
[
"History",
"or",
"clinical",
"suspicion",
"of",
"neurofibromatosis"
] |
[
0,
0,
0,
0,
0,
2
] |
NCT02081404
|
12:25:treatment
|
A negative esophageal pH result and absence of erosions will be inclusion criteria for these patients
| 1
|
[
"A",
"negative",
"esophageal",
"pH",
"result",
"and",
"absence",
"of",
"erosions",
"will",
"be",
"inclusion",
"criteria",
"for",
"these",
"patients"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02914483
|
1:19:chronic_disease
|
pulmonary embolism
| 1
|
[
"pulmonary",
"embolism"
] |
[
2,
2
] |
NCT02234934
|
1:12:chronic_disease,,
|
Neutropenia (absolute granulocyte count <1,000/mm3)
| 1
|
[
"Neutropenia",
"(",
"absolute",
"granulocyte",
"count",
"<",
"1,000/mm3",
")"
] |
[
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT00959140
|
1:4:chronic_disease
|
HIV positive patients
| 1
|
[
"HIV",
"positive",
"patients"
] |
[
2,
0,
0
] |
NCT02141074
|
32:45:chronic_disease,,
|
Patients with the diagnosis of haemophilia B (FIX (coagulation factor IX) activity level below or equal to 2%) based on medical records or central laboratory results
| 1
|
[
"Patients",
"with",
"the",
"diagnosis",
"of",
"haemophilia",
"B",
"(",
"FIX",
"(",
"coagulation",
"factor",
"IX",
")",
"activity",
"level",
"below",
"or",
"equal",
"to",
"2",
"%",
")",
"based",
"on",
"medical",
"records",
"or",
"central",
"laboratory",
"results"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02276443
|
,,71:106:treatment,110:131:treatment,,166:176:treatment
|
Patients must have left ventricular ejection fraction (LVEF) > 50% by multi gated acquisition scan (MUGA) or echocardiogram (ECHO) within 12 weeks prior to starting adriamycin
| 1
|
[
"Patients",
"must",
"have",
"left",
"ventricular",
"ejection",
"fraction",
"(",
"LVEF",
")",
">",
"50",
"%",
"by",
"multi",
"gated",
"acquisition",
"scan",
"(",
"MUGA",
")",
"or",
"echocardiogram",
"(",
"ECHO",
")",
"within",
"12",
"weeks",
"prior",
"to",
"starting",
"adriamycin"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02369770
|
1:15:chronic_disease
|
Pressure ulcer
| 1
|
[
"Pressure",
"ulcer"
] |
[
2,
2
] |
NCT02816736
|
1:26:chronic_disease
|
constrictive pericarditis
| 1
|
[
"constrictive",
"pericarditis"
] |
[
2,
2
] |
NCT02347891
|
12:30:cancer,,86:105:cancer,107:112:cancer,116:129:cancer
|
History of malignant neoplasm within the last 5 years, except for adequately treated cancers of the skin (basal or squamous cell)
| 1
|
[
"History",
"of",
"malignant",
"neoplasm",
"within",
"the",
"last",
"5",
"years",
",",
"except",
"for",
"adequately",
"treated",
"cancers",
"of",
"the",
"skin",
"(",
"basal",
"or",
"squamous",
"cell",
")"
] |
[
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
0,
3,
3,
0
] |
NCT03131037
|
44:56:allergy_name
|
Known sensitivity or allergic reactions to valacyclovir
| 1
|
[
"Known",
"sensitivity",
"or",
"allergic",
"reactions",
"to",
"valacyclovir"
] |
[
0,
0,
0,
0,
0,
0,
4
] |
NCT02721303
|
1:18:treatment
|
Bariatric surgery
| 1
|
[
"Bariatric",
"surgery"
] |
[
1,
1
] |
NCT02581982
|
1:58:treatment,60:103:treatment,108:157:treatment
|
Prior therapy with an anti-programmed cell death 1 (PD-1), anti-programmed cell death-ligand 1 (PD-L1), or anti-programmed cell death-ligand 2 (PD-L2) agent
| 1
|
[
"Prior",
"therapy",
"with",
"an",
"anti-programmed",
"cell",
"death",
"1",
"(",
"PD-1",
")",
",",
"anti-programmed",
"cell",
"death-ligand",
"1",
"(",
"PD-L1",
")",
",",
"or",
"anti-programmed",
"cell",
"death-ligand",
"2",
"(",
"PD-L2",
")",
"agent"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02452697
|
34:54:chronic_disease
|
This may include patients with a mixed chimeric state or disease persistence or at high risk of relapse
| 1
|
[
"This",
"may",
"include",
"patients",
"with",
"a",
"mixed",
"chimeric",
"state",
"or",
"disease",
"persistence",
"or",
"at",
"high",
"risk",
"of",
"relapse"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.